Acceptability and feasibility of human papillomavirus vaccination for adolescents in school environments in Libreville


  • Nathalie L. Ambounda Department of Cancer Prevention and Control Program, Faculty of Medicine and Health Sciences, University of Health Sciences, Libreville, Gabon
  • Sylvain H. Woromogo Department of Health Programme Management and Epidemiology, Inter-State Centre for Higher Education in Public Health of Central Africa (CIESPAC), Brazzaville, Republic of Congo
  • Olive M. Kenmogne Department of Obstetrics Gynecology, University Hospital Centre, Libreville, Gabon
  • Felicite E. Yagata Moussa Department of Preventive Medicine and Epidemiological Surveillance, Ministry of Public Health, Bangui, Central African Republic, Central Africa
  • Vicky N. Simo Tekem Department of Cancer Prevention and Control Program, Regional Hospital Centre of Koulamoutou, Ministry of Public Health, Libreville, Gabon
  • Eliane O. Ango Department of Cancer Prevention and Control Program, Health Centre of Nzeng Ayong, Ministry of Public Health, Libreville, Gabon



Acceptability, Adolescents, Feasibility, Human papillomavirus, School environments


Background: High-risk oncogenic human papillomaviruses (HPV) are the cause of sexually transmitted viral infection. Its persistence is a risk factor for precancerous lesions of the cervix, which will constitute the base of cervical cancer. In the world, the prevalence of high-risk oncogenic HPV is 66.7%, which is higher among women starting their sexual activity.

Methods: An analytical cross-sectional study was conducted in high schools in Gabon regarding parents. The variables selected were the socio-cultural and demographic characteristics of the parents, their knowledge of human papillomavirus vaccination and their acceptability of HPV vaccination and finally the feasibility of HPV vaccination. The statistical test used was Pearson's Chi-square, and a difference was considered significant for p<0.05.

Results: The majority of parents, 89%, were informed of the existence of cervical cancer. However, 73.4% of them were unaware of the existence of vaccination against cervical cancer. Only 2.4% of parents had vaccinated their daughters against cervical cancer at the time of the study. These parents only 53.4% expressed an interest in vaccinating their daughters in 53.4% of cases. The ability to vaccinate children is associated with the socio-professional status of parents (p˂0.000).

Conclusions: The majority of parents approved school-based vaccination against human papillomavirus infections despite its reported cost and lack of information. The integration of anti-HPV vaccination into the expanded programme on immunization in Gabon will improve immunization coverage.


Riethmuller D, Schaal JP, Mougin C. Epidemiology and natural history of human papilomavirus genital infection. Gynecol Obstet Fert. 2002;30(2):139-46.

Ljubojevic S, Skerlev M. HPV - associated diseases. Clin Dermatol. 2014;32(2):227-34.

Gavillon N, Vervaet H, Derniaux E, Terrosi P, Graesslin O, Quereux C. How did I contract human Papillomavirus (HPV)?. Gynecol Obstet Fert. 2010;38(3):199-204.

Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-27.

WHO. Human papillomavirus (HPV) and cervical cancer, 2019. Available at: Accessed on 12th May 2020.

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-53.

Dalstein V, Briolat J, Birembaut P, Clavel C. The epidemiology of genital human papillomavirus infections. Rev Prat. 2006;56(17):1877-81.

Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30:F12-23.

Gabonese Republic. Overall results of the 2013 general population and housing census RGPL2013), 2013. Available at: Accessed on 14th May 2020.

Guechot M. Vaccination against papillomavirus: factors involved in the decision to vaccinate. 2018, Available at: Accessed on 26th August 2020.

Jaspers L, Budiningsih S, Wolterbeek R, Henderson FC, Peters AA. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study. Vaccine. 2011;29(44):7785-93.

Khan SS. Parental acceptance of the Human Papillomavirus vaccination among South Asian immigrants living in the Midwest USA. Available at: Accessed on 14th May 2020.

Grandahl M, Chun Paek S, Grisurapong S, Sherer P, Tyden T, Lundberg P. Parents’ knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand. PloS One. 2018;13(2):e0193054.

Haesebaert J, Lutringer-Magnin D, Kalecinski J, Barone G, Jacquard AC, Régnier V, et al. French women’s knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14-18 year old daughters: a quantitative-qualitative study. BMC Public Health. 2012;12(1):1034.

McBride KR, Singh S. Predictors of adults' knowledge and awareness of HPV, HPV-associated cancers, and the HPV vaccine: implications for health education. Health Educ Behav. 2018;45(1):68-76.

He J, He L. Knowledge of HPV and acceptability of HPV vaccine among women in western China: a cross-sectional survey. BMC Womens Health. 2018;18(1):130.

Lutringer-Magnin D, Kalecinski J, Barone G, Leocmach Y, Regnier V, Jacquard AC, et al. Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing. Vaccine. 2011;29(32):5322-8.

Palmeri S, Costantino C, D’Angelo C, Casuccio N, Ventura G, Vitale F, et al. HPV vaccine hesitancy among parents of female adolescents: a pre-post interventional study. Public Health. 2017;150:84-6.

Cheruvu VK, Bhatta MP, Drinkard LN. Factors associated with parental reasons for “no-intent” to vaccinate female adolescents with human papillomavirus vaccine: National immunization survey - teen 2008-2012. BMC Pediatr. 2017;17:52-6.

Restivo V, Costantino C, Fazio TF, Casuccio N, D’Angelo C, Vitale F, et al. Factors associated with HPV vaccine refusal among young adult women after ten years of vaccine implementation. Int J Environ Res Public Health. 2018;15(4):770.

Blaisdell LL, Gutheil C, Hootsmans NA, Han PK. Unknown risks: parental hesitation about vaccination. Med Decis Making. 2016;36(4):479-89.

Hanson KE, McLean HQ, Belongia EA, Stokley S, McNeil MM, Gee J, et al. Sociodemographic and clinical correlates of human papillomavirus vaccine attitudes and receipt among Wisconsin adolescents. Papillomavirus Res. 2019;8:100168.

VanWormer JJ, Bendixsen CG, Vickers ER, Stokley S, McNeil MM, Gee J, et al. Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents. BMC Public Health. 2017;17(1):766.

Sherman SM, Nailer E. Attitudes towards and knowledge about human papillomavirus (HPV) and the HPV vaccination in parents of teenage boys in the UK. PLos One. 2018;13(4):e195801.

Kurup L, He HG, Wang X, Wang W, Shorey S. A descriptive qualitative study of perceptions of parents on their child's vaccination. J Clin Nurs. 2017;26(23-24):4857-67.






Original Research Articles